Molecular abnormalities are prevalent in solid tumor
formation and progression. Molecular genetic
markers for loci associated with breast, prostate, and
lung tumors are routinely used for prognostication.
Other solid tumors, including soft tissue tumors, are
characterized by unique molecular endpoints easily
targetable by both FISH and molecular strategies.
TEST SCHEDULES
TESTS 
